News | March 19, 2025
Croda opens advanced lipids manufacturing facility in Pennsylvania
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Increases speed to market for drug developers working on nucleic acid therapeutics
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
Subscribe To Our Newsletter & Stay Updated
